Search Results - "Sugai, Shoichiro"

Refine Results
  1. 1

    Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity by Kobayashi, Akio, Suzuki, Yusuke, Sugai, Shoichiro

    Published in Journal of toxicological sciences (2020)
    “…The activities of the transaminases (aminotransferases) alanine aminotransferase and aspartate aminotransferase in the blood (serum or plasma) are widely used…”
    Get full text
    Journal Article
  2. 2

    Enhancement of acetaminophen-induced chronic hepatotoxicity in spontaneously diabetic torii (SDT) rats by Kondo, Kazuma, Yamada, Naohito, Suzuki, Yusuke, Hashimoto, Tatsuji, Toyoda, Kaoru, Takahashi, Tadakazu, Kobayashi, Akio, Sugai, Shoichiro, Yoshinari, Kouichi

    Published in Journal of toxicological sciences (01-01-2020)
    “…Some patients encounter hepatotoxicity after repeated acetaminophen (APAP) dosing even at therapeutic doses. In the present study, we focused on the diabetic…”
    Get full text
    Journal Article
  3. 3

    Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis by Goda, Keisuke, Saito, Kosuke, Muta, Kyotaka, Kobayashi, Akio, Saito, Yoshiro, Sugai, Shoichiro

    Published in Journal of toxicological sciences (01-01-2018)
    “…Valproic acid (VPA) is known to induce hepatic steatosis due to mitochondrial toxicity in rodents and humans. In the present study, we administered VPA to SD…”
    Get full text
    Journal Article
  4. 4

    Arachidonic acid‐containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen‐induced hepatic phospholipidosis by Saito, Kosuke, Goda, Keisuke, Kobayashi, Akio, Yamada, Naohito, Maekawa, Kyoko, Saito, Yoshiro, Sugai, Shoichiro

    Published in Journal of applied toxicology (01-08-2017)
    “…Lipid profiling has emerged as an effective approach to not only screen disease and drug toxicity biomarkers but also understand their underlying mechanisms of…”
    Get full text
    Journal Article
  5. 5

    High fructose diet feeding accelerates diabetic nephropathy in Spontaneously Diabetic Torii (SDT) rats by Toyoda, Kaoru, Suzuki, Yusuke, Muta, Kyotaka, Masuyama, Taku, Kakimoto, Kochi, Kobayashi, Akio, Shoda, Toshiyuki, Sugai, Shoichiro

    Published in Journal of toxicological sciences (01-01-2018)
    “…Diabetic nephropathy (DN) is one of the complications of diabetes and is now the most common cause of end-stage renal disease. Fructose is a simple…”
    Get full text
    Journal Article
  6. 6

    Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury by Goda, Keisuke, Takahashi, Tadakazu, Kobayashi, Akio, Shoda, Toshiyuki, Kuno, Hideyuki, Sugai, Shoichiro

    Published in Journal of toxicological sciences (2016)
    “…Drug-induced liver injury (DILI) is one of the serious and frequent drug-related adverse events. This adverse event is a main reason for regulatory action…”
    Get full text
    Journal Article
  7. 7

    A pharmacologic increase in activity of plasma transaminase derived from small intestine in animals receiving an acyl CoA: diacylglycerol transferase (DGAT) 1 inhibitor by Yokoyama, Hideaki, Kobayashi, Akio, Kondo, Kazuma, Oshida, Shin-ichi, Takahashi, Tadakazu, Masuyama, Taku, Shoda, Toshiyuki, Sugai, Shoichiro

    Published in Journal of toxicological sciences (01-01-2018)
    “…Acyl CoA: diacylglycerol acyltransferase (DGAT) 1 is an enzyme that catalyzes the re-synthesis of triglycerides (TG) from free fatty acids and diacylglycerol…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Investigation of Predisposition Biomarkers to Identify Risk Factors for Drug-induced Liver Injury in Humans: Analyses of Endogenous Metabolites in an Animal Model Mimicking Human Responders to APAP-induced Hepatotoxicity by Kobayashi, Akio, Kondo, Kazuma, Sugai, Shoichiro

    Published in YAKUGAKU ZASSHI (2015)
    “…Drug-induced liver injury is a main reason of regulatory action pertaining to drugs, including restrictions to clinical indications and withdrawal from the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats by Kobayashi, Akio, Suzuki, Yusuke, Kuno, Hideyuki, Sugai, Shoichiro, Sakakibara, Hiroyuki, Shimoi, Kayoko

    Published in Journal of toxicological sciences (01-08-2009)
    “…Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels are widely used as sensitive markers of possible tissue damage, particularly…”
    Get full text
    Journal Article
  13. 13

    Effects of spaced feeding on gene expression of hepatic transaminase and gluconeogenic enzymes in rats by Kobayashi, Akio, Yokoyama, Hideaki, Kataoka, Jiro, Ishida, Tomio, Kuno, Hideyuki, Sugai, Shoichiro, Sakakibara, Hiroyuki, Shimoi, Kayoko

    Published in Journal of toxicological sciences (01-06-2011)
    “…Blood alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities are widely used as sensitive markers of liver toxicity. However, these…”
    Get full text
    Journal Article
  14. 14

    Relationships between plasma and tissue transaminase activities in rats maintained under different feeding conditions by Kobayashi, Akio, Oshida, Shin-ichi, Yamazaki, Yuji, Maekawa, Tatsuya, Kuno, Hideyuki, Sugai, Shoichiro, Sakakibara, Hiroyuki, Shimoi, Kayoko

    Published in Journal of toxicological sciences (01-10-2010)
    “…In order to verify the nutritional aspect of alterations of the plasma and tissue transaminase activities, rats were fed 4 hr per day for 35 days (the…”
    Get full text
    Journal Article
  15. 15

    臨床薬剤性肝障害リスク因子特定のためのバイオマーカーの探索:endogenous metabolite解析によるアセトアミノフェン誘発性肝障害に対する感受性予測 by 小林, 章男, 近藤, 千真, 菅井, 象一郎

    Published in YAKUGAKU ZASSHI (01-05-2015)
    “…「1. はじめに」 医薬品による薬剤性肝障害(drug induced liver injury; DILI)は, 規制当局による医薬品の適応制限や市場からの医薬品の撤退につながることがある重大な副作用の1つである. 製薬企業にとって開発化合物のDILI誘発性評価の精度を向上させることは,…”
    Get full text
    Journal Article
  16. 16

    Effects of Delgocitinib Ointment 0.5% on the Normal Mouse Skin and Epidermal Tight Junction Proteins in Comparison With Topical Corticosteroids by Anagawa-Nakamura, Akiko, Ryoke, Katsunori, Yasui, Yuzo, Shoda, Toshiyuki, Sugai, Shoichiro

    Published in Toxicologic pathology (01-12-2020)
    “…Delgocitinib ointment 0.5% is the world’s first topical Janus kinase inhibitor product and was approved for treatment of atopic dermatitis (AD) in Japan…”
    Get full text
    Journal Article
  17. 17

    Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide‐induced hepatic steatosis in rats by Muta, Kyotaka, Saito, Kosuke, Kemmochi, Yusuke, Masuyama, Taku, Kobayashi, Akio, Saito, Yoshiro, Sugai, Shoichiro

    Published in Journal of applied toxicology (01-09-2022)
    “…Ethionamide (ETH), a second‐line drug for multidrug‐resistant tuberculosis, is known to cause hepatic steatosis in rats and humans. To investigate predictive…”
    Get full text
    Journal Article
  18. 18

    URINARY EXCRETION OF OXIDATIVE METABOLITES OF BILIRUBIN IN FENOFIBRATE-TREATED RATS by KOBAYASHI, Akio, TAKAHASHI, Tadakazu, SUGAI, Shoichiro, MIYAKAWA, Yoshifumi, IWATSUKA, Hisashi, YAMAGUCHI, Tokio

    Published in Journal of toxicological sciences (01-01-2003)
    “…Bilirubin oxidative metabolites (BOM) were shown to be excreted into the urine in rats in which exaggerated oxidative stress was induced. We measured bilirubin…”
    Get full text
    Journal Article
  19. 19
  20. 20